This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BERRY, S. J. Articles by ISAACS, J. T. Search for Related Content PubMed PubMed Citation Articles by BERRY, S. J. Articles by ISAACS, J. T.

Comparative Aspects of Prostatic Growth and Androgen Metabolism with Aging in the Dog Versus the Rat^*

Department of Population Dynamics, The Johns Hopkins School of Hygiene and Public Health Baltimore, Maryland 21205
Department of Urology, and The Oncology Center, The Johns Hopkins University School of Medicine Baltimore, Maryland 21205
The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital Baltimore, Maryland 21205

Address correspondence and requests for reprints to: Dr. John T. Isaacs, Ph.D., James Buchanan Brady Urological Institute, Research Laboratories, The Johns Hopkins Hospital, Baltimore, Maryland 21205.

Abstract

In untreated rats and dogs, there is a speciesspecific time period when proliferative growth of the prostate normally occurs during which the gland grows to its maximum normal cellular content. In both species, after the prostate has reached its maximum normal cellular content, which requires 1 yr for the rat and 2 yr for the dog, net proliferative prostatic growth ceases and is replaced by a steady state maintenance of the gland. When 2-yr-old dogs with starting prostates already at their maximum normal cellular content are subsequently treated for 4 months with dihydrotestosterone (DHT), such treatment induces an additional 2-fold abnormal proliferative increase in prostatic cell number above that seen in normal glands from untreated dogs of any age. In direct contrast to the dog, when rats are treated with exogenous DHT for as long as 650 days, such treatment cannot induce any abnormal overgrowth of the gland above the maximum size normally obtained by 365 days of life in untreated control rats.

Studies of prostatic androgen metabolism suggest that the differential susceptibility of the dog and rat prostate to DHTinduced abnormal hyperplasia is related to the differential ability of DHT treatment to increase the gland’s ability for net DHT formation. This suggestion is based upon the fact that only in the DHT-treated dog, and not the rat, can such DHT treatment induce changes in several of the prostatic activities of DHT metabolism resulting in a 2.5-fold increase in the gland’s overall ability for net DHT formation. These results indicate that changes in prostatic DHT metabolism which result in an increased prostatic ability for net DHT formation may be essential in abnormal hyperplasia of the prostate. (Endocrinology 114: 511, 1984)

Footnotes

^* This study was supported by NIH Grant AM-19300.

Received December 16, 1982.

This article has been cited by other articles:

				C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF]

				C. Morrissey, A. Buser, J. Scolaro, J. O'Sullivan, A. Moquin, and M. Tenniswood Changes in Hormone Sensitivity in the Ventral Prostate of Aging Sprague-Dawley Rats J Androl, May 1, 2002; 23(3): 341 - 351. [Abstract] [Full Text] [PDF]

				P. P. Banerjee, S. Banerjee, J. M. Lai, J. D. Strandberg, B. R. Zirkin, and T. R. Brown Age-Dependent and Lobe-Specific Spontaneous Hyperplasia in the Brown Norway Rat Prostate Biol Reprod, November 1, 1998; 59(5): 1163 - 1170. [Abstract] [Full Text]

				H. Wennbo, J. Kindblom, O. G. P. Isaksson, and J. Tornell Transgenic Mice Overexpressing the Prolactin Gene Develop Dramatic Enlargement of the Prostate Gland Endocrinology, October 1, 1997; 138(10): 4410 - 4415. [Abstract] [Full Text] [PDF]